Search
Now showing items 1-10 of 16
Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and Azacitidine
Pratz, Keith W. et al. (2022)
Wissenschaftlicher Artikel
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
Estey, Elihu; Hasserjian, Robert P.; Döhner, Hartmut (2022)
Wissenschaftlicher Artikel
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Ng, Yuen Lam Dora et al. (2022)
Wissenschaftlicher Artikel
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia
Huber, Henriette et al. (2022)
Wissenschaftlicher Artikel
Challenges of Hematopoietic Stem Cell Transplantation in the Era of COVID-19
Esagian, Stepan M. et al. (2022)
Wissenschaftlicher Artikel
Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies
Garcia-Manero, Guillermo et al. (2022)
Wissenschaftlicher Artikel
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
Bloehdorn, Johannes et al. (2022)
Wissenschaftlicher Artikel
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
Zapatka, Marc et al. (2022)
Wissenschaftlicher Artikel
Ivosidenib and Azacitidine in IDH1-Mutated AML REPLY
Montesinos, Pau; de Botton, Stephane; Döhner, Hartmut (2022)
Wissenschaftlicher Artikel
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
Zhai, Yanan et al. (2022)
Wissenschaftlicher Artikel